Haemonetics Corporation disclosed that director Martin D. Madaus acquired 2,538 restricted stock units on July 24, 2026, as part of the company's equity compensation program. The RSUs, which vest over one year, represent a standard component of board compensation at the Boston-based medical device …
Haemonetics Corporation announced on July 24, 2026, that its Board of Directors elected Martin Madaus, a healthcare investment advisor at The Carlyle Group, as a new director effective immediately. In the same meeting, shareholders overwhelmingly approved amendments to the company's long-term incentive plan and …
Slide Insurance Holdings, Inc. disclosed its financial performance for the second quarter and first half of 2026 in an announcement dated July 28, 2026. The Delaware-incorporated insurer, trading on the Nasdaq Global Select Market under the ticker SLDE, filed a current report with the …
Equitable Holdings, Inc. announced on July 28, 2026, that its Board of Directors has scheduled the 2026 annual meeting of stockholders for September 23, 2026, at 12:00 p.m. Eastern Time. The company has also established August 7, 2026, as the record date for voting …
Richtech Robotics Inc. (NASDAQ: RR), a Nevada-incorporated technology company, disclosed that it received a notice from Nasdaq on May 22, 2026, regarding non-compliance with listing rules due to the delayed filing of its Quarterly Report for the period ended March 31, 2026. The company …
XMax Inc. (NASDAQ: XMAX) secured shareholder approval on July 24, 2026, for two substantial equity issuances that will dilute existing shareholders' ownership. The Nevada-based company won permission to sell more than 20% of its outstanding common stock through both a private placement and a …
Chemed Corporation disclosed its financial results for the quarter ended June 30, 2026, in a current report filed on July 28, 2026. The company, which operates through its VITAS and Roto-Rooter divisions, issued the announcement to provide investors with updated performance metrics for the …
The Cheesecake Factory Incorporated announced its second quarter fiscal 2026 financial results on July 28, 2026, and disclosed that its Board of Directors approved a quarterly cash dividend of $0.30 per share payable on August 25, 2026. The company also updated its investor presentation …
NeuroPace Inc. disclosed on July 28, 2026, that the U.S. Food and Drug Administration has determined that its Premarket Approval Supplement for the RNS System is not approvable in its current form. The submission sought to expand the labeled indication to include patients with …
Veralto Corporation disclosed its financial results for the quarter ended July 3, 2026, on July 28, 2026. The announcement provided investors with updated operational and financial performance metrics for the second quarter of the fiscal year. The disclosure marks a routine quarterly earnings announcement …